Serum follicle-stimulating hormone level is a predictor of bone mineral density in patients with hormone replacement therapy

Archives of Gynecology and Obstetrics

Volumn 269, Issue 3, 2004, Pages 192-195

  Kawai, Haruko ^a   Furuhashi, Madoka ^a,c   Suganuma, Nobuhiko ^b  

^a Handa City Hospital   (Japan)

^b TOYOHASHI MUNICIPAL HOSPITAL   (Japan)

^c JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

Author keywords

Bone mineral density; Estradiol; Follicle stimulating hormone; Hormone replacement therapy; Luteinizing hormone

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL; FOLLITROPIN; GONADOTROPIN; LUTEINIZING HORMONE; MEDROXYPROGESTERONE ACETATE;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE MINERAL; DISEASE MARKER; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; GONADOTROPIN BLOOD LEVEL; HORMONE SUBSTITUTION; HUMAN; LUMBAR SPINE; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; RETROSPECTIVE STUDY;

ADULT; AGED; BIOLOGICAL MARKERS; BONE DENSITY; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; LUTEINIZING HORMONE; MEDICAL RECORDS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES;

EID: 1642307909     PISSN: 09320067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00404-003-0532-7     Document Type: Article

References (22)

1. Belchetz PE (1994) Hormonal treatment of postmenopausal women. N Engl J Med 330:1062-1071
2. Blain H, Vuillemin A, Guillemin F, Durant R, Hanesse B, De Talance N, Doucet B, Jeandel C (2002) Serum leptin level is a predictor of bone mineral density in postmenopausal women. J Clin Endocrinol Metab 87:1030-1035
3. Casson PR, Elkind-Hirsch KE, Buster JE, Hornsby PJ, Carson SA, Snabes MC (1997) Effect of postmenopausal estrogen replacement on circulating androgens. Obstet Gynecol 90:995-998
4. Chung KW, Kim MR, Yoo SW, Kwon DJ, Lim YT, Kim JH, Lee JW (2000) Can bone turnover markers correlate bone mass at the hip and spine according to menopausal period? Arch Gynecol Obstet 264:119-123
5. Cummings SR, Browner WS, Bauer D, Stone K, Ensrud K, Jamal S, Ettinger B (1998) Endogenous hormones and the risk of hip and vertebral fractures among older women. N Engl J Med 339:733-738
6. Ettinger B, Pressman A, Sklarin P, Bauer DC, Cauley JA, Cummings SR (1998) Associations between low levels of serum estradiol, bone density, and fractures among elderly women: the study of osteoporotic fractures. J Clin Endocrinol Metab 83:2239-2243
7. Genazzani AD, Petraglia F, Gastaldi M, Volpogni C, Gamba O, Massolo F, Genazzani AR (1994) Evidence suggesting an additional control mechanism regulating episodic secretion of luteinizing hormone and follicle stimulating hormone in prepubertal children and post-menopausal women. Hum Reprod 9:1807-1812
8. Genazzani AD, Petraglia F, Sgarbi L, Montanini V, Hartmann B, Surico N, Biolcati A, Volpe A, Genazzani AR (1997) Difference of LH and FSH secretory characteristics and degree of concordance between postmenopausal and aging women. Maturitas 26:133-138
9. Hall JE, Lavoie HB, Marsh EE, Martin KA (2000) Decrease in gonadotropin-releasing hormone (GnRH) pulse frequency with aging in postmenopausal women. J Clin Endocrinol Metab 85:1794-1800
10. Johnston CC Jr, Slemenda CW, Melton LJ III (1991) Clinical use of bone densitometry. N Engl J Med 324:1105-1109
11. Keen RW, Nguyen T, Sobnack R, Perry LA, Thompson PW, Spector TD (1996) Can biochemical markers predict bone loss at the hip and spine?: a [sic] 4-year prospective study of 141 early postmenopausal women. Osteoporosis Int 6:399-406
12. Kuhl H (1990) Pharmacokinetics of oestrogens and progestogens. Maturitas 12:171-197
13. Nand SL, Wren BG, Gross BA, Heller GZ (1999) Bone density effects of continuous estrone sulfate and varying doses of medroxyprogesterone acetate. Obstet Gynecol 93:1009-1013
14. Rossmanith WG, Scherbaum WA, Lauritzen C (1991) Gonadotropin secretion during aging in postmenopausal women. Neuroendocrinology 54:211-218
15. Rossmanith WG, Handke-Vesely A, Wirth U, Scherbaum WA (1994) Does the gonadotropin pulsatility of postmenopausal women represent the unrestrained hypothalamic-pituitary activity? Eur J Endocrinol 130:485-493
16. Rossmanith WG, Reichelt C, Scherbaum WA (1994) Neuroendocrinology of aging in humans: attenuated sensitivity to sex steroid feedback in elderly postmenopausal women. Neuroendocrinology 59:355-362
17. Santoro N, Banwell T, Tortoriello D, Lieman H, Adel T, Skurnick J (1998) Effects of aging and gonadal failure on the hypothalamic-pituitary axis in women. Am J Obstet Gynecol 178:732-741
18. Sharpless JL, Supko JG, Martin KA, Hall JE (1999) Disappearance of endogenous luteinizing hormone is prolonged in postmenopausal women. J Clin Endocrinol Metab 84:688-694
19. Slemenda C, Longcope C, Peacock M, Hui S, Johnston CC (1996) Sex steroids, bone mass, and bone loss: a prospective study of pre-, peri-, and postmenopausal women. J Clin Invest 97:14-21
20. Stone K, Bauer DC, Black DM, Sklarin P, Ensrud KE, Cummings SR (1998) Hormonal predictors of bone loss in elderly women: a prospective study. J Bone Miner Res 13:1167-1174
21. Ulloa-Aguirre A, Midgley AR Jr, Beitins IZ, Padmanabhan V (1995) Follicle-stimulating isohormones: characterization and physiological relevance. Endocr Rev 16:765-787
22. World Health Organization (1996) Research on the menopause in the 1990s: report of a WHO scientific group. World Health Organ Tech Rep Ser 866:1-107